Ticker
RLYBCompany Name
RALLYBIO CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Debt to Equity Ratio | Shareholders Equity | Total Liabilities |
---|---|---|---|
6/30/2025 | 0.11 | $ 45.96M | $ 5.04M |
3/31/2025 | 0.07 | $ 54.07M | $ 3.91M |
12/31/2024 | 0.1 | $ 61.65M | $ 6.45M |
9/30/2024 | 0.12 | $ 70.82M | $ 8.19M |
6/30/2024 | 0.16 | $ 80.02M | $ 12.41M |
3/31/2024 | 0.11 | $ 89.16M | $ 10.2M |
12/31/2023 | 0.09 | $ 106.18M | $ 9.44M |
9/30/2023 | 0.08 | $ 123.58M | $ 9.61M |
6/30/2023 | 0.06 | $ 139.26M | $ 8.32M |
3/31/2023 | 0.05 | $ 155.2M | $ 7.12M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Liabilities / Equity
(=) D/E
D/E for RALLYBIO CORP is calculated as follows: Liabilities [ $ 5.86M ] / Equity [ $ -46.02M ]
(=) D/E [ 0 ]
Minimum
Dec 31, 2021
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 3.3K |
---|---|
min | 0 |
max | 6.05 |
average | 1.39 |
median | 0.98 |
std | 1.31 |